Back to results
US 6,280,728 B1Granted
Treatment of hepatitis C virus infection using a protease and a flavonoid
AssigneeMucos Pharma GmbH & Co.
InventorsGerhard Stauder, Karl Ransberger
Life of this patent
Estimating the term…
Abstract
The use of at least one hydrolytic enzyme and at least one flavonoid shows better activity than α-interferon or ribavirin in the treatment of diseases caused by hepatitis C viruses.
Claims6
A method of treating a Hepatitis C virus infection, the method comprising administering to a patient infected with the virus at least one proteolytic enzyme and at least one flavonoid selected from the group consisting of rutoside, rutoside derivatives, metabolites of rutoside, and preparations of Gingko Biloba.
Dependencies are inferred from the claim text.